Piribedil
Piribedil (Trivastan) is a dopamine D2/D3 receptor agonist employed in Parkinson's disease research. It is utilized in both in vitro binding assays and in vivo models to study dopaminergic pathways, neurodegeneration, and motor function.
Product Specifications
CAS Number
3605-01-4
Product Name Alternative
ET 495, ET495, ET-495, EU 4200, EU4200, EU-4200, Inhibitor, HistoneMethyltransferase, Histone Methyltransferase, leukemia, MLL1, Parkinson's, MV4, locomotor activity, inhibit, AdrenergicReceptor, Adrenergic Receptor, anti-leukemic, cancer, Beta Receptor, Dopamine Receptor, DopamineReceptor, dyskinesias, Dopamine, D2, D3, Piribedil, THP-1, α2-adrenergic, Trivastal, Trivastan
Field of Research
Epigenetics & Chromatin, Neuroscience, Pharmacology & Drug Discovery
Purity
99.79% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.7 mM) ; Chloroform:Soluble; DMSO:18.33 mg/mL (61.44 mM)
Smiles
C (N1CCN (CC1) C1=NC=CC=N1) C1=CC2=C (OCO2) C=C1
Molecular Formula
C16H18N4O2
Molecular Weight
298.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2446-55A 100 µg
CD105 (Endoglin, gp160, TGF beta1,3 Receptor, HHT1, ORW1, Osler Rendu Weber syndrome 1) (FITC)
Sign In for Pricing
View Details